Article info
Neurodegeneration
Viewpoint
Genetic screening in sporadic ALS and FTD
- Correspondence to Professor Martin R Turner, Nuffield Department of Clinical Neurosciences, West Wing Level 6, John Radcliffe Hospital, Oxford, OX3 9DU, UK; martin.turner{at}ndcn.ox.ac.uk
Citation
Genetic screening in sporadic ALS and FTD
Publication history
- Received March 7, 2017
- Revised May 3, 2017
- Accepted May 22, 2017
- First published June 22, 2017.
Online issue publication
November 28, 2017
Article Versions
- Previous version (22 June 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/